Abhishek Chaturvedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abhishek Chaturvedi has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Apeksha Chaturvedi
Imaging Science, University of Rochester Medical Center, 601, Elmwood Avenue, Rochester, NY, 14642, USA
5 shared publications- Apeksha Chaturvedi
Division of Pediatric Radiology, Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USA
4 shared publications Susan K. Hobbs
Univ Rochester Med Ctr, Rochester, NY USA
3 shared publicationsTimothy Baran
Univ Rochester, Med Ctr, Dept Imaging Sci, 601 Elmwood Ave, Rochester, NY 14642 USA
3 shared publicationsKatherine Kaproth-Joslin
Univ Rochester Med Ctr, Rochester, NY USA
2 shared publications- Katherine Kaproth-Joslin
Department of Imaging Sciences-Cardiothoracic Imaging, University of Rochester Medical Center, 691 Elmwood Ave, Rochester, NY 14642
2 shared publications
Latest Publications
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (2) , e250113
Right Ventricular Assist Devices: Radiographic and CT Findings with Illustrations
This review highlights the importance of radiography and CT in evaluating right ventricular assist devices, after placement and in detection of complications.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (2) , e250113
Right Ventricular Assist Devices: Radiographic and CT Findings with Illustrations
This review highlights the importance of radiography and CT in evaluating right ventricular assist devices, after placement and in detection of complications.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (4) , e240218
Left Ventricular Assist Devices: Advances, Complications, and Pitfalls
CT imaging is important in the identification of left ventricular assist device–associated complications.
- 1 August 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 7 (4) , e240218
Left Ventricular Assist Devices: Advances, Complications, and Pitfalls
CT imaging is important in the identification of left ventricular assist device–associated complications.
- 1 June 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (6) , e230126
Radiologic-Pathologic Correlation of Cardiac Tumors: Updated 2021 WHO Tumor Classification
Cardiac tumors, although rare, carry high morbidity and mortality rates. They are commonly first identified either at echocardiography or incidentally at thoracoabdominal CT performed for noncardiac indications. Multimodality imaging often helps to determine the cause of these masses. Cardiac tumors comprise a distinct category in the World Health Organization (WHO) classification of tumors. The updated 2021 WHO classification of tumors of the heart incorporates new entities and reclassifies others. In the new classification system, papillary fibroelastoma is recognized as the most common primary cardiac neoplasm. Pseudotumors including thrombi and anatomic variants (eg, crista terminalis, accessory papillary muscles, or coumadin ridge) are the most common intracardiac masses identified at imaging. Cardiac metastases are substantially more common than primary cardiac tumors. Although echocardiography is usually the first examination, cardiac MRI is the modality of choice for the identification and characterization of cardiac masses. Cardiac CT serves as an alternative in patients who cannot tolerate MRI. PET performed with CT or MRI enables metabolic characterization of malignant cardiac masses. Imaging individualized to a particular tumor type and location is crucial for treatment planning. Tumor terminology changes as our understanding of tumor biology and behavior evolves. Familiarity with the updated classification system is important as a guide to radiologic investigation and medical or surgical management. ©RSNA, 2024 Supplemental material is available for this article.
- 1 June 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (6) , e230126
Radiologic-Pathologic Correlation of Cardiac Tumors: Updated 2021 WHO Tumor Classification
Cardiac tumors, although rare, carry high morbidity and mortality rates. They are commonly first identified either at echocardiography or incidentally at thoracoabdominal CT performed for noncardiac indications. Multimodality imaging often helps to determine the cause of these masses. Cardiac tumors comprise a distinct category in the World Health Organization (WHO) classification of tumors. The updated 2021 WHO classification of tumors of the heart incorporates new entities and reclassifies others. In the new classification system, papillary fibroelastoma is recognized as the most common primary cardiac neoplasm. Pseudotumors including thrombi and anatomic variants (eg, crista terminalis, accessory papillary muscles, or coumadin ridge) are the most common intracardiac masses identified at imaging. Cardiac metastases are substantially more common than primary cardiac tumors. Although echocardiography is usually the first examination, cardiac MRI is the modality of choice for the identification and characterization of cardiac masses. Cardiac CT serves as an alternative in patients who cannot tolerate MRI. PET performed with CT or MRI enables metabolic characterization of malignant cardiac masses. Imaging individualized to a particular tumor type and location is crucial for treatment planning. Tumor terminology changes as our understanding of tumor biology and behavior evolves. Familiarity with the updated classification system is important as a guide to radiologic investigation and medical or surgical management. ©RSNA, 2024 Supplemental material is available for this article.
- 20 December 2023
- Published by Elsevier in Seminars in Roentgenology
- Vol. 59 (1) , 20-31
Role of Magnetic Resonance Imaging in Transcatheter Structural Heart Disease Interventions
- 20 December 2023
- Published by Elsevier in Seminars in Roentgenology
- Vol. 59 (1) , 20-31
Role of Magnetic Resonance Imaging in Transcatheter Structural Heart Disease Interventions
- Open Access
- 16 July 2023
- Published by Springer Nature in Insights into Imaging
- Vol. 14 (1) , 1-14
CT and chest radiography in evaluation of mechanical circulatory support devices for acute heart failure
Acute heart failure and cardiogenic shock are a major cause of morbidity and mortality in patients who have had recent cardiac surgery, myocardial infarct or pulmonary hypertension. The use of percutaneous mechanical circulatory support (MCS) devices before organ failure occurs can improve outcomes in these patients. Imaging plays a key role in identifying appropriate positioning of MCS devices for supporting ventricle function. These devices can be used for left ventricle, right ventricle or biventricular support. Fluoroscopy, angiography and echocardiography are used for implanting these devices. Radiographs and CT can identify both intra- and extra-cardiac complications. The cardiothoracic imager will see increasing use of these devices and familiarity with their normal appearance and complications is important. Critical relevance statement: Chest radiographs and CT are useful for assessing the position of the mechanical cardiac support device used for treatment of acute heart failure. CT can identify cardiac and extra-cardiac complications associated with these devices. Graphical Key points: IABP upper/distal marker should be 2–3 cm distal to the ostia of the left subclavian artery. Inlet of Impella CP should be 3.5 cm below the aortic valve. The Impella 5.5 does not have a pigtail portion. The inlet should be about 5 cm below the aortic annulus. Impella RP inlet port should be in the right atrium or inferior vena cava, the pigtail portion should be positioned in the main pulmonary artery. Protek Duo inflow is in the right atrium or right ventricle. The outflow is in the main pulmonary artery.
- 16 July 2023
- Published by Springer Nature in Insights into Imaging
- Vol. 14 (1) , 1-14
Open AccessCT and chest radiography in evaluation of mechanical circulatory support devices for acute heart failure
Acute heart failure and cardiogenic shock are a major cause of morbidity and mortality in patients who have had recent cardiac surgery, myocardial infarct or pulmonary hypertension. The use of percutaneous mechanical circulatory support (MCS) devices before organ failure occurs can improve outcomes in these patients. Imaging plays a key role in identifying appropriate positioning of MCS devices for supporting ventricle function. These devices can be used for left ventricle, right ventricle or biventricular support. Fluoroscopy, angiography and echocardiography are used for implanting these devices. Radiographs and CT can identify both intra- and extra-cardiac complications. The cardiothoracic imager will see increasing use of these devices and familiarity with their normal appearance and complications is important. Critical relevance statement: Chest radiographs and CT are useful for assessing the position of the mechanical cardiac support device used for treatment of acute heart failure. CT can identify cardiac and extra-cardiac complications associated with these devices. Graphical Key points: IABP upper/distal marker should be 2–3 cm distal to the ostia of the left subclavian artery. Inlet of Impella CP should be 3.5 cm below the aortic valve. The Impella 5.5 does not have a pigtail portion. The inlet should be about 5 cm below the aortic annulus. Impella RP inlet port should be in the right atrium or inferior vena cava, the pigtail portion should be positioned in the main pulmonary artery. Protek Duo inflow is in the right atrium or right ventricle. The outflow is in the main pulmonary artery.
- 13 December 2022
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 38 (4) , W44-W51
Standardized Criteria for Identification of Cardiac Tamponade on Non–Electrocardiogram-gated Computed Tomography
Purpose: To identify imaging parameters that can help in the diagnosis of cardiac tamponade on non–electrocardiogram (ECG)-gated computed tomography (CT) of the chest. Materials and Methods: Retrospective analysis of 64 patients who had undergone CT and echocardiography for evaluation of cardiac tamponade. Of 64 patients, 34 were diagnosed with tamponade and underwent pericardiocentesis for further diagnosis and treatment. CT measurements obtained were: pericardial effusion (PeEff) pocket size in 6 locations (anterior, posterior, superior, inferior, right, and left lateral), pericardial thickening, diameters of the coronary sinus, upper superior vena cava, lower superior vena cava, and inferior vena cava. In addition, cardiac chamber sizes were measured. Subjective assessment of coronary sinus compression, pericardial enhancement, and pericardial thickening were also recorded. Results: Measurement of the sum of the right lateral and left lateral PeEff thickness resulted in 91.2% sensitivity and 86.7% specificity for cardiac tamponade with a threshold of 30 mm (receiver-operating characteristic area under the curve=0.94 [0.84 to 0.98], P16 mm, sum of right lateral and left lateral PeEff>30 mm, and presence of pericardial thickening resulted in 56% sensitivity and 100% specificity and positive predictive value for the determination of cardiac tamponade. Conclusions: Our study suggests that CT measurements related to PeEff size and thickness aid in the diagnosis of cardiac tamponade.
- 13 December 2022
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 38 (4) , W44-W51
Standardized Criteria for Identification of Cardiac Tamponade on Non–Electrocardiogram-gated Computed Tomography
Purpose: To identify imaging parameters that can help in the diagnosis of cardiac tamponade on non–electrocardiogram (ECG)-gated computed tomography (CT) of the chest. Materials and Methods: Retrospective analysis of 64 patients who had undergone CT and echocardiography for evaluation of cardiac tamponade. Of 64 patients, 34 were diagnosed with tamponade and underwent pericardiocentesis for further diagnosis and treatment. CT measurements obtained were: pericardial effusion (PeEff) pocket size in 6 locations (anterior, posterior, superior, inferior, right, and left lateral), pericardial thickening, diameters of the coronary sinus, upper superior vena cava, lower superior vena cava, and inferior vena cava. In addition, cardiac chamber sizes were measured. Subjective assessment of coronary sinus compression, pericardial enhancement, and pericardial thickening were also recorded. Results: Measurement of the sum of the right lateral and left lateral PeEff thickness resulted in 91.2% sensitivity and 86.7% specificity for cardiac tamponade with a threshold of 30 mm (receiver-operating characteristic area under the curve=0.94 [0.84 to 0.98], P16 mm, sum of right lateral and left lateral PeEff>30 mm, and presence of pericardial thickening resulted in 56% sensitivity and 100% specificity and positive predictive value for the determination of cardiac tamponade. Conclusions: Our study suggests that CT measurements related to PeEff size and thickness aid in the diagnosis of cardiac tamponade.
- 1 September 2021
- Published by Elsevier in Clinical Imaging
- Vol. 77, 122-129
Improving CT assessment for pulmonary hypertension in patients with severe aortic stenosis, correlation with right heart catheterization
- 1 September 2021
- Published by Elsevier in Clinical Imaging
- Vol. 77, 122-129
Improving CT assessment for pulmonary hypertension in patients with severe aortic stenosis, correlation with right heart catheterization
- 1 April 2021
- Published by Elsevier in Clinical Imaging
- Vol. 72, 97-113
Imaging of acute gastric emergencies: a case-based review
- 1 April 2021
- Published by Elsevier in Clinical Imaging
- Vol. 72, 97-113
Imaging of acute gastric emergencies: a case-based review
- 1 September 2020
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 35 (5) , 309-316
Identification of Patients With Heart Failure From Test Bolus of Computed Tomography Angiography in Patients Undergoing Preoperative Evaluation for Transcatheter Aortic Valve Replacement
Purpose: Identify a measurable parameter from test bolus of computed tomography angiography that can differentiate aortic stenosis patients with normal systolic function from those with heart failure and reduced ejection fraction (HFrEF). Materials and Methods: This retrospective study included patients (undergoing evaluation for transcatheter aortic valve replacement) who had retrospective electrocardiogram-gated cardiac computed tomography angiography using test bolus. The measured variables were time to peak contrast enhancement in the pulmonary artery (PA(time)), in the ascending (AsAo(time)) and descending aorta (DsAo(time)). From these, the pulmonary transit time (PTT: difference between time to peak enhancement in the ascending aorta to peak enhancement in the main pulmonary artery), aortic transit time (ATT: difference between time to peak enhancement in the descending aorta to time to peak enhancement in the ascending aorta) and DsAo(time)-PA(time)were also calculated. Biventricular volumes and function were calculated. The subjects were classified on the basis of ventricular ejection fractions: normal (EF>50%), midrange (EF 40% to 50%), and HF patients with reduced EF (EF23 seconds in the ascending or descending aorta.
- 1 September 2020
- Published by Wolters Kluwer Health in Journal of Thoracic Imaging
- Vol. 35 (5) , 309-316
Identification of Patients With Heart Failure From Test Bolus of Computed Tomography Angiography in Patients Undergoing Preoperative Evaluation for Transcatheter Aortic Valve Replacement
Purpose: Identify a measurable parameter from test bolus of computed tomography angiography that can differentiate aortic stenosis patients with normal systolic function from those with heart failure and reduced ejection fraction (HFrEF). Materials and Methods: This retrospective study included patients (undergoing evaluation for transcatheter aortic valve replacement) who had retrospective electrocardiogram-gated cardiac computed tomography angiography using test bolus. The measured variables were time to peak contrast enhancement in the pulmonary artery (PA(time)), in the ascending (AsAo(time)) and descending aorta (DsAo(time)). From these, the pulmonary transit time (PTT: difference between time to peak enhancement in the ascending aorta to peak enhancement in the main pulmonary artery), aortic transit time (ATT: difference between time to peak enhancement in the descending aorta to time to peak enhancement in the ascending aorta) and DsAo(time)-PA(time)were also calculated. Biventricular volumes and function were calculated. The subjects were classified on the basis of ventricular ejection fractions: normal (EF>50%), midrange (EF 40% to 50%), and HF patients with reduced EF (EF23 seconds in the ascending or descending aorta.
- 1 May 2020
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 40 (3) , 754-774
Acute Fractures and Dislocations of the Ankle and Foot in Children
An understanding of the normal developmental anatomy of the pediatric foot and ankle and the injury mechanisms and imaging manifestations of acute foot and ankle injuries aids in ensuring appropria... Distinct biologic and mechanical attributes of the pediatric skeleton translate into fracture patterns, complications, and treatment dilemmas that differ from those of adults. In children, increasi...
- 1 May 2020
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 40 (3) , 754-774
Acute Fractures and Dislocations of the Ankle and Foot in Children
An understanding of the normal developmental anatomy of the pediatric foot and ankle and the injury mechanisms and imaging manifestations of acute foot and ankle injuries aids in ensuring appropria... Distinct biologic and mechanical attributes of the pediatric skeleton translate into fracture patterns, complications, and treatment dilemmas that differ from those of adults. In children, increasi...